DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies

被引:30
作者
Bellier, Bertrand [2 ,3 ,4 ]
Huret, Christophe [2 ,3 ,4 ]
Miyalou, Mathilde [2 ,3 ,4 ]
Desjardins, Delphine [1 ,2 ,3 ,4 ]
Frenkiel, Marie-Pascale [5 ,6 ]
Despres, Philippe [5 ,6 ]
Tangy, Frederic [7 ]
Dalba, Charlotte [8 ]
Klatzmann, David [1 ,2 ,3 ,4 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France
[2] UPMC Univ Paris 06, UMR7211, I3, F-75013 Paris, France
[3] CNRS, UMR7211, I3, F-75013 Paris, France
[4] INSERM, UMR S959, I3, F-75013 Paris, France
[5] Inst Pasteur, F-75015 Paris, France
[6] Ctr Natl Reference Arbovirus, F-75015 Paris, France
[7] CNRS, URA3015, F-75015 Paris, France
[8] EPIXIS SA, F-75013 Paris, France
关键词
DNA vaccine; Virus-like particle; Neutralizing antibody; VIRUS-LIKE PARTICLES; CLASS-I PRESENTATION; HEPATITIS-B-VIRUS; PLASMID DNA; IMMUNE-RESPONSES; GENETIC IMMUNIZATION; ANTIGEN PATTERNS; MEASLES-VACCINE; CHALLENGE; HIV-1;
D O I
10.1016/j.vaccine.2009.07.059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We aimed at improving DNA vaccination efficiency for inducing neutralizing antibodies. We used plasmids encoding Gag of MLV and envelope proteins of VSV or WNV. Upon in vivo injection, they generate retrovirus-derived VLPs pseudotyped with these envelopes expressed in their wild-type conformation. We show that these plasmo-retroVLPs induce potent humoral responses, the efficacy of which could be improved by co-administration of DNA encoding adjuvant cytokines. Antibodies against VSV or WNV were detected earlier than with plasmids not generating VLPs, and had higher neutralizing activities. These results highlight the potential of this approach for vaccination strategies aiming at neutralizing antibody induction. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5772 / 5780
页数:9
相关论文
共 60 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   CD8+ T cell efficacy in vaccination and disease [J].
Appay, Victor ;
Douek, Daniel C. ;
Price, David A. .
NATURE MEDICINE, 2008, 14 (06) :623-628
[3]   Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine [J].
Arrode, Geraldine ;
Hegde, Ramakrishna ;
Jin, Yuhuai ;
Singh, Dinesh Kumar ;
Narayan, Opendra ;
Chebloune, Yahia .
VACCINE, 2008, 26 (31) :3795-3804
[4]  
Bachmann MF, 1997, J IMMUNOL, V158, P5106
[5]   THE INFLUENCE OF ANTIGEN ORGANIZATION ON B-CELL RESPONSIVENESS [J].
BACHMANN, MF ;
ROHRER, UH ;
KUNDIG, TM ;
BURKI, K ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
SCIENCE, 1993, 262 (5138) :1448-1451
[6]   Neutralizing antiviral B cell responses [J].
Bachmann, MF ;
Zinkernagel, RM .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :235-270
[7]   T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? [J].
Bachmann, MF ;
Hengartner, H ;
Zinkernagel, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (12) :3445-3451
[8]   T-cell-independent antiviral B cell responses in CD45-deficient mice [J].
Bachmann, MF ;
Kundig, TM ;
Speiser, DE ;
McKallFaienza, K ;
Kishara, K ;
Mak, TW ;
Ohashi, PS .
CELLULAR IMMUNOLOGY, 1997, 175 (01) :12-15
[9]   Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8(+) cytotoxic T lymphocytes [J].
Bachmann, MF ;
Lutz, MB ;
Layton, GT ;
Harris, SJ ;
Fehr, T ;
Rescigno, M ;
RicciardiCastagnoli, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) :2595-2600
[10]   Jet-induced skin puncture and its impact on needle-free jet injections: Experimental studies and a predictive model [J].
Baxter, J ;
Mitragotri, S .
JOURNAL OF CONTROLLED RELEASE, 2005, 106 (03) :361-373